- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: CC-95775
Total 835 results
-
CelgeneCompletedLeukemia Lymphocytic Chronic B-CellUnited States, Austria
-
Yale UniversityCelgene CorporationCompletedMultiple MyelomaUnited States
-
Celgene CorporationPrologue Research InternationalCompletedNon-Small Cell Lung CancerUnited States
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsNot yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Thomas HopeCompleted
-
The Leprosy Mission NepalRecruitingLeprosy | Erythema Nodosum LeprosumNepal
-
CelgeneActive, not recruitingMultiple MyelomaFrance, United States, Canada, Spain, Italy
-
Sir Mortimer B. Davis - Jewish General HospitalCompleted
-
Kadmon Corporation, LLCCompletedIdiopathic Pulmonary FibrosisUnited States
-
Celgene CorporationCompletedCrohn's DiseaseFrance, United States, United Kingdom, Israel
-
UNC Lineberger Comprehensive Cancer CenterActive, not recruiting
-
Yale UniversityPatient-Centered Outcomes Research InstituteActive, not recruiting
-
University of ArkansasCelgeneCompletedMultiple MyelomaUnited States
-
University Health Network, TorontoCompletedMicrosatellite Stable Colorectal Carcinoma | Platinum Resistant Epithelial Ovarian Cancer Type II | Estrogen Receptor Positive and HER2 Negative Breast CancerCanada
-
CelgeneCompleted
-
CelgeneCompletedMultiple MyelomaUnited States
-
Celgene CorporationCompletedMultiple MyelomaUnited States
-
Celgene CorporationCompletedMelanoma | Neoplasm MetastasisUnited States, Canada
-
Jonsson Comprehensive Cancer CenterNot yet recruitingProstate Carcinoma | Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
Mayo ClinicRecruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationRecruitingAML, Adult | Relapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITDFrance
-
CelgeneCompletedNeoplasmsUnited States, France, Italy, Poland, Spain, United Kingdom
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Spain
-
University of MichiganCompletedProstate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
CelgeneTerminatedLeukemia, MyeloidUnited States, France, Belgium, Spain
-
CelgeneCompleted
-
CelgeneCompletedMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterCelgeneCompletedLeukemia | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLLUnited States
-
Washington University School of MedicineCompletedLeukemia, Myeloid, AcuteUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
UNC Lineberger Comprehensive Cancer CenterWithdrawn
-
CelgeneActive, not recruitingLeukemia, Myeloid, AcuteUnited States, Australia, Brazil, Canada, Czechia, Finland, France, Germany, Italy, Korea, Republic of, Mexico, Portugal, Russian Federation, Spain, United Kingdom, Belgium, Taiwan, Austria, Ireland, Israel, Lithuania, Poland, Turkey
-
Stanford UniversityCelgene CorporationWithdrawnPulmonary FibrosisUnited States
-
University of California, DavisCelgeneCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
University of Santiago de CompostelaMinisterio de Economía y Competitividad, Spain; Ministry of Work and Welfare...Completed
-
Mayo ClinicNational Cancer Institute (NCI)CompletedChronic Myeloproliferative Disorders | Secondary MyelofibrosisUnited States
-
CelgeneTerminatedSoft Tissue SarcomaUnited States
-
CelgeneCompletedMultiple MyelomaCanada, Denmark, Australia, Belgium, France, Germany, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom, Czechia, Greece
-
CelgenePrologue Research InternationalCompleted
-
The Lymphoma Academic Research OrganisationCelgene CorporationCompletedRelapsed/Refractory B-cell LymphomaFrance
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States, Denmark, Australia, Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedPain | Advanced CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
Southern Europe New Drug OrganizationCelgene CorporationUnknown
-
Medical University of South CarolinaCelgene CorporationCompletedLarge B-Cell Diffuse LymphomaUnited States
-
CelgeneCompletedMyelodysplastic SyndromeSpain, United Kingdom, Denmark, Germany, France, Greece, Italy, Sweden, Belgium, United States, Luxembourg, Norway
-
Weill Medical College of Cornell UniversityTerminated